Silence Therapeutics (OTCMKTS:SLNCF – Get Free Report) is one of 383 public companies in the “Biotechnology” industry, but how does it contrast to its rivals? We will compare Silence Therapeutics to similar companies based on the strength of its profitability, dividends, valuation, analyst recommendations, institutional ownership, earnings and risk. Insider & Institutional Ownership 7.9% of […]
Silence Therapeutics (OTCMKTS:SLNCF – Free Report) is one of 370 public companies in the “Biotechnology” industry, but how does it weigh in compared to its peers? We will compare Silence Therapeutics to similar businesses based on the strength of its dividends, institutional ownership, risk, profitability, valuation, earnings and analyst recommendations. Analyst Ratings This is a […]
Silence Therapeutics (OTCMKTS:SLNCF – Free Report) is one of 374 public companies in the “Biotechnology” industry, but how does it weigh in compared to its rivals? We will compare Silence Therapeutics to similar businesses based on the strength of its analyst recommendations, dividends, risk, earnings, profitability, institutional ownership and valuation. Institutional and Insider Ownership 7.9% […]
Silence Therapeutics (OTCMKTS:SLNCF – Free Report) is one of 370 public companies in the “Biotechnology” industry, but how does it weigh in compared to its rivals? We will compare Silence Therapeutics to related companies based on the strength of its earnings, institutional ownership, profitability, dividends, valuation, risk and analyst recommendations. Earnings and Valuation This table […]
Silence Therapeutics (OTCMKTS:SLNCF – Free Report) is one of 376 publicly-traded companies in the “Biotechnology” industry, but how does it weigh in compared to its competitors? We will compare Silence Therapeutics to related companies based on the strength of its analyst recommendations, institutional ownership, dividends, risk, profitability, valuation and earnings. Institutional and Insider Ownership 7.9% […]